What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?

Jana de Boniface, Marcus Schmidt, Jutta Engel, Marjolein L. Smidt, Birgitte Vrou Offersen, Toralf Reimer

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)331-336
Number of pages6
JournalBreast Care
Volume13
Issue number5
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Breast cancer
  • Axillary surgery
  • Sentinel lymph node biopsy
  • Radiotherapy
  • INTERNATIONAL EXPERT CONSENSUS
  • SENTINEL NODE BIOPSY
  • ELECTIVE RADIATION-THERAPY
  • RANDOMIZED CLINICAL-TRIAL
  • TARGET VOLUME DELINEATION
  • NON-INFERIORITY TRIAL
  • PHASE-III
  • FOLLOW-UP
  • AXILLARY DISSECTION
  • DOSE-DENSE

Cite this

de Boniface, J., Schmidt, M., Engel, J., Smidt, M. L., Offersen, B. V., & Reimer, T. (2018). What Is the Best Management of cN0pN1(sn) Breast Cancer Patients? Breast Care, 13(5), 331-336. https://doi.org/10.1159/000491704